
AstraZeneca deepens China presence with FibroGen deal
Dive Brief: FibroGen agreed to sell its Chinese subsidiary to AstraZeneca in a deal worth $160 million, giving the biotech funds to pay off a loan and extend its cash runway. The transaction allows FibroGen to keep about $75 million in cash currently held …